Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220


The Policy and Practice Legacy of the New Jersey Medicaid ACO Demonstration Project.

DeLia D, Yedidia MJ.

J Ambul Care Manage. 2020 Jan/Mar;43(1):2-10. doi: 10.1097/JAC.0000000000000308.


Healthy Food Access in Low-Income High-Minority Communities: A Longitudinal Assessment-2009-2017.

Ohri-Vachaspati P, DeWeese RS, Acciai F, DeLia D, Tulloch D, Tong D, Lorts C, Yedidia M.

Int J Environ Res Public Health. 2019 Jul 3;16(13). pii: E2354. doi: 10.3390/ijerph16132354.


Accuracy of Parent-Measured and Parent-Estimated Heights and Weights in Determining Child Weight Status.

Ohri-Vachaspati P, Acciai F, DeLia D, Lloyd K, Yedidia MJ.

JAMA Pediatr. 2019 Jun 17. doi: 10.1001/jamapediatrics.2019.1545. [Epub ahead of print] No abstract available.


DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients.

Corti A, Sota R, Dugo M, Calogero RA, Terragni B, Mantegazza M, Franceschetti S, Restelli M, Gasparini P, Lecis D, Chrzanowska KH, Delia D.

Sci Rep. 2019 Jan 24;9(1):651. doi: 10.1038/s41598-018-36912-0.


Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.

Tsui J, DeLia D, Stroup AM, Nova J, Kulkarni A, Ferrante JM, Cantor JC.

Cancer. 2019 Apr 15;125(8):1330-1340. doi: 10.1002/cncr.31824. Epub 2018 Dec 18.


TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.

Magni M, Buscemi G, Maita L, Peng L, Chan SY, Montecucco A, Delia D, Zannini L.

Cell Death Differ. 2019 May;26(5):918-931. doi: 10.1038/s41418-018-0168-6. Epub 2018 Jul 26.


cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells.

Majorini MT, Manenti G, Mano M, De Cecco L, Conti A, Pinciroli P, Fontanella E, Tagliabue E, Chiodoni C, Colombo MP, Delia D, Lecis D.

Cell Death Differ. 2018 Dec;25(12):2147-2164. doi: 10.1038/s41418-018-0100-0. Epub 2018 Apr 19.


MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.

Andriani F, Majorini MT, Mano M, Landoni E, Miceli R, Facchinetti F, Mensah M, Fontanella E, Dugo M, Giacca M, Pastorino U, Sozzi G, Delia D, Roz L, Lecis D.

J Hematol Oncol. 2018 Mar 20;11(1):45. doi: 10.1186/s13045-018-0594-4.


Separase prevents genomic instability by controlling replication fork speed.

Cucco F, Palumbo E, Camerini S, D'Alessio B, Quarantotti V, Casella ML, Rizzo IM, Cukrov D, Delia D, Russo A, Crescenzi M, Musio A.

Nucleic Acids Res. 2018 Jan 9;46(1):267-278. doi: 10.1093/nar/gkx1172.


The DNA damage response pathway in normal hematopoiesis and malignancies.

Delia D, Mizutani S.

Int J Hematol. 2017 Sep;106(3):328-334. doi: 10.1007/s12185-017-2300-7. Epub 2017 Jul 13. Review.


Determinants of Sugar-Sweetened Beverage Consumption among Low-Income Children: Are There Differences by Race/Ethnicity, Age, and Sex?

Tasevska N, DeLia D, Lorts C, Yedidia M, Ohri-Vachaspati P.

J Acad Nutr Diet. 2017 Dec;117(12):1900-1920. doi: 10.1016/j.jand.2017.03.013. Epub 2017 May 8.


Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.

Conti A, Majorini MT, Fontanella E, Bardelli A, Giacca M, Delia D, Mano M, Lecis D.

Cancer Lett. 2017 Mar 28;389:59-69. doi: 10.1016/j.canlet.2016.12.025. Epub 2016 Dec 29.


Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.

Piao J, Takai S, Kamiya T, Inukai T, Sugita K, Ohyashiki K, Delia D, Masutani M, Mizutani S, Takagi M.

Cancer Lett. 2017 Feb 1;386:131-140. doi: 10.1016/j.canlet.2016.11.021. Epub 2016 Nov 25.


A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation.

Restelli M, Magni M, Ruscica V, Pinciroli P, De Cecco L, Buscemi G, Delia D, Zannini L.

Cell Death Dis. 2016 Nov 3;7(11):e2453. doi: 10.1038/cddis.2016.359.


Mortality, Disenrollment, and Spending Persistence in Medicaid and CHIP.

DeLia D.

Med Care. 2017 Mar;55(3):220-228. doi: 10.1097/MLR.0000000000000648.


The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells.

Tomasella A, Picco R, Ciotti S, Sgorbissa A, Bianchi E, Manfredini R, Benedetti F, Trimarco V, Frezzato F, Trentin L, Semenzato G, Delia D, Brancolini C.

Oncotarget. 2016 Jul 19;7(29):45429-45443. doi: 10.18632/oncotarget.9742.


SMC1B is present in mammalian somatic cells and interacts with mitotic cohesin proteins.

Mannini L, Cucco F, Quarantotti V, Amato C, Tinti M, Tana L, Frattini A, Delia D, Krantz ID, Jessberger R, Musio A.

Sci Rep. 2015 Dec 17;5:18472. doi: 10.1038/srep18472.


Prehospital transportation to therapeutic hypothermia centers and survival from out-of-hospital cardiac arrest.

DeLia D, Wang HE, Kutzin J, Merlin M, Nova J, Lloyd K, Cantor JC.

BMC Health Serv Res. 2015 Dec 2;15:533. doi: 10.1186/s12913-015-1199-z.


Monte Carlo Analysis of Payer and Provider Risks in Shared Savings Arrangements.

DeLia D.

Med Care Res Rev. 2016 Oct;73(5):511-31. doi: 10.1177/1077558715618320. Epub 2015 Nov 27.


Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.

Conti A, Majorini MT, Elliott R, Ashworth A, Lord CJ, Cancelliere C, Bardelli A, Seneci P, Walczak H, Delia D, Lecis D.

Oncotarget. 2015 May 10;6(13):10994-1008.


Patterns of emergency department use for dental and oral health care: implications for dental and medical care coordination.

DeLia D, Lloyd K, Feldman CA, Cantor JC.

J Public Health Dent. 2016 Winter;76(1):1-8. doi: 10.1111/jphd.12103. Epub 2015 May 20.


Drawing Plausible Inferences about the Impact of State Dependent Coverage Expansions.

Monheit AC, Cantor JC, DeLia D.

Health Serv Res. 2015 Jun;50(3):631-6. doi: 10.1111/1475-6773.12313. No abstract available.


Impact of Medicare Part D on coverage, access, and disparities among new jersey seniors.

Chakravarty S, Gaboda D, DeLia D, Cantor JC, Nova J.

Med Care Res Rev. 2015 Apr;72(2):127-48. doi: 10.1177/1077558714563762. Epub 2014 Dec 28.


Bimodal regulation of p21(waf1) protein as function of DNA damage levels.

Buscemi G, Ricci C, Zannini L, Fontanella E, Plevani P, Delia D.

Cell Cycle. 2014;13(18):2901-12. doi: 10.4161/15384101.2014.946852.


CHK2 kinase in the DNA damage response and beyond.

Zannini L, Delia D, Buscemi G.

J Mol Cell Biol. 2014 Dec;6(6):442-57. doi: 10.1093/jmcb/mju045. Epub 2014 Nov 17. Review.


The relative contribution of layers of the Social Ecological Model to childhood obesity.

Ohri-Vachaspati P, DeLia D, DeWeese RS, Crespo NC, Todd M, Yedidia MJ.

Public Health Nutr. 2015 Aug;18(11):2055-66. doi: 10.1017/S1368980014002365. Epub 2014 Nov 6.


Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.

Magni M, Ruscica V, Buscemi G, Kim JE, Nachimuthu BT, Fontanella E, Delia D, Zannini L.

Nucleic Acids Res. 2014 Dec 1;42(21):13150-60. doi: 10.1093/nar/gku1065. Epub 2014 Oct 31.


Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10.

Raulf N, El-Attar R, Kulms D, Lecis D, Delia D, Walczak H, Papenfuss K, Odell E, Tavassoli M.

Br J Cancer. 2014 Nov 11;111(10):1955-64. doi: 10.1038/bjc.2014.521. Epub 2014 Oct 14.


The New Jersey Medicaid ACO Demonstration Project: seeking opportunities for better care and lower costs among complex low-income patients.

Cantor JC, Chakravarty S, Tong J, Yedidia MJ, Lontok O, DeLia D.

J Health Polit Policy Law. 2014 Dec;39(6):1185-211. doi: 10.1215/03616878-2822622. Epub 2014 Sep 23.


EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.

Möller Y, Siegemund M, Beyes S, Herr R, Lecis D, Delia D, Kontermann R, Brummer T, Pfizenmaier K, Olayioye MA.

PLoS One. 2014 Sep 8;9(9):e107165. doi: 10.1371/journal.pone.0107165. eCollection 2014.


Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency.

Carlessi L, Fusar Poli E, Bechi G, Mantegazza M, Pascucci B, Narciso L, Dogliotti E, Sala C, Verpelli C, Lecis D, Delia D.

Cell Death Dis. 2014 Jul 17;5:e1342. doi: 10.1038/cddis.2014.310.


Post-discharge follow-up visits and hospital utilization by Medicare patients, 2007-2010.

DeLia D, Tong J, Gaboda D, Casalino LP.

Medicare Medicaid Res Rev. 2014 May 9;4(2). pii: mmrr.004.02.a01. doi: 10.5600/mmrr.004.02.a01. eCollection 2014.


Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins.

Mingozzi M, Manzoni L, Arosio D, Dal Corso A, Manzotti M, Innamorati F, Pignataro L, Lecis D, Delia D, Seneci P, Gennari C.

Org Biomol Chem. 2014 May 28;12(20):3288-302. doi: 10.1039/c4ob00207e. Epub 2014 Apr 16.


TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.

Agorreta J, Hu J, Liu D, Delia D, Turley H, Ferguson DJ, Iborra F, Pajares MJ, Larrayoz M, Zudaire I, Pio R, Montuenga LM, Harris AL, Gatter K, Pezzella F.

Mol Cancer Res. 2014 May;12(5):660-9. doi: 10.1158/1541-7786.MCR-13-0481. Epub 2014 Feb 24.


The fragmentation of hospital use among a cohort of high utilizers: implications for emerging care coordination strategies for patients with multiple chronic conditions.

Hempstead K, Delia D, Cantor JC, Nguyen T, Brenner J.

Med Care. 2014 Mar;52 Suppl 3:S67-74. doi: 10.1097/MLR.0000000000000049.


Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma.

Gatti L, De Cesare M, Ciusani E, Corna E, Arrighetti N, Cominetti D, Belvisi L, Potenza D, Moroni E, Vasile F, Lecis D, Delia D, Castiglioni V, Scanziani E, Seneci P, Zaffaroni N, Perego P.

Mol Pharm. 2014 Jan 6;11(1):283-93. doi: 10.1021/mp4004578. Epub 2013 Nov 27.


Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.

Lecis D, De Cesare M, Perego P, Conti A, Corna E, Drago C, Seneci P, Walczak H, Colombo MP, Delia D, Sangaletti S.

Cell Death Dis. 2013 Nov 14;4:e920. doi: 10.1038/cddis.2013.449.


Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved.

Fusar Poli E, Zalfa C, D'Avanzo F, Tomanin R, Carlessi L, Bossi M, Nodari LR, Binda E, Marmiroli P, Scarpa M, Delia D, Vescovi AL, De Filippis L.

Cell Death Dis. 2013 Nov 7;4:e906. doi: 10.1038/cddis.2013.430.


Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells.

Verpelli C, Carlessi L, Bechi G, Fusar Poli E, Orellana D, Heise C, Franceschetti S, Mantegazza R, Mantegazza M, Delia D, Sala C.

Front Cell Neurosci. 2013 Oct 7;7:175. doi: 10.3389/fncel.2013.00175. eCollection 2013.


A closer examination of the relationship between children's weight status and the food and physical activity environment.

Ohri-Vachaspati P, Lloyd K, Delia D, Tulloch D, Yedidia MJ.

Prev Med. 2013 Sep;57(3):162-7. doi: 10.1016/j.ypmed.2013.05.009. Epub 2013 May 30.


ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration.

Carlessi L, Fusar Poli E, De Filippis L, Delia D.

DNA Repair (Amst). 2013 Aug;12(8):605-11. doi: 10.1016/j.dnarep.2013.04.013. Epub 2013 May 23. Review.


Post-cardiac arrest therapeutic hypothermia in New Jersey hospitals: analysis of adoption and implementation.

DeLia D, Wang HE, Kutzin J, Merlin M, Cantor JC.

Ther Hypothermia Temp Manag. 2012 Jun;2(2):78-88.


Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL).

Scavullo C, Servida F, Lecis D, Onida F, Drago C, Ferrante L, Seneci P, Barcellini W, Lionetti M, Todoerti K, Neri A, Delia D, Deliliers GL.

Leuk Res. 2013 Jul;37(7):809-15. doi: 10.1016/j.leukres.2013.03.016. Epub 2013 Apr 22.


Brain and induced pluripotent stem cell-derived neural stem cells as an in vitro model of neurodegeneration in ataxia-telangiectasia.

Carlessi L, Fusar Poli E, Delia D.

Exp Biol Med (Maywood). 2013 Mar;238(3):301-7. doi: 10.1177/1535370213480703. Review.


Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.

Cossu F, Milani M, Vachette P, Malvezzi F, Grassi S, Lecis D, Delia D, Drago C, Seneci P, Bolognesi M, Mastrangelo E.

PLoS One. 2012;7(11):e49527. doi: 10.1371/journal.pone.0049527. Epub 2012 Nov 15.


Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization.

Lecis D, Mastrangelo E, Belvisi L, Bolognesi M, Civera M, Cossu F, De Cesare M, Delia D, Drago C, Manenti G, Manzoni L, Milani M, Moroni E, Perego P, Potenza D, Rizzo V, Scavullo C, Scolastico C, Servida F, Vasile F, Seneci P.

Bioorg Med Chem. 2012 Nov 15;20(22):6709-23. doi: 10.1016/j.bmc.2012.09.041. Epub 2012 Sep 24.


Early impact of the Affordable Care Act on health insurance coverage of young adults.

Cantor JC, Monheit AC, DeLia D, Lloyd K.

Health Serv Res. 2012 Oct;47(5):1773-90. doi: 10.1111/j.1475-6773.2012.01458.x. Epub 2012 Aug 27.


DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.

Zannini L, Buscemi G, Kim JE, Fontanella E, Delia D.

J Mol Cell Biol. 2012 Oct;4(5):294-303. doi: 10.1093/jmcb/mjs035. Epub 2012 Jun 26.


Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.

Lopergolo A, Tavecchio M, Lisanti S, Ghosh JC, Dohi T, Faversani A, Vaira V, Bosari S, Tanigawa N, Delia D, Kossenkov AV, Showe LC, Altieri DC.

Cancer Res. 2012 Jul 1;72(13):3251-9. doi: 10.1158/0008-5472.CAN-11-4035. Epub 2012 May 14.

Supplemental Content

Support Center